The Quality of Life after Breast Cancer — Solving the Problem of Lymphedema
- 4 February 1999
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 340 (5), 383-385
- https://doi.org/10.1056/nejm199902043400511
Abstract
In the past 30 years we have witnessed an assault on the view that breast cancer can be treated as a regional disease solely by aggressive surgical techniques. First to be challenged and abandoned was radical mastectomy, and soon afterward segmental mastectomy or lumpectomy was demonstrated to be as effective as modified radical mastectomy.1 Sentinel-node biopsy, which may lead to the elimination of axillary dissection in women with early-stage disease, represents the newest challenge to traditional surgical approaches to the treatment and staging of breast cancer.2 These changes have been driven by a better understanding of the systemic nature of . . .Keywords
This publication has 10 references indexed in Scilit:
- Lack of Effect of Coumarin in Women with Lymphedema after Treatment for Breast CancerNew England Journal of Medicine, 1999
- Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast CancerJNCI Journal of the National Cancer Institute, 1998
- Sentinel-Lymph-Node Biopsy for Breast Cancer — Not Yet the Standard of CareNew England Journal of Medicine, 1998
- The Sentinel Node in Breast Cancer — A Multicenter Validation StudyNew England Journal of Medicine, 1998
- Tamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast CancerJNCI Journal of the National Cancer Institute, 1997
- Pain and other symptoms during the first year after radical and conservative surgery for breast cancerBritish Journal of Cancer, 1996
- Recent Trends in U.S. Breast Cancer Incidence, Survival, and Mortality RatesJNCI Journal of the National Cancer Institute, 1996
- Focused review: Postmastectomy lymphedemaArchives of Physical Medicine and Rehabilitation, 1996
- Treatment of Lymphedema of the Arms and Legs with 5,6-Benzo-[alpha]-pyroneNew England Journal of Medicine, 1993
- NIH consensus conference. Treatment of early-stage breast cancerPublished by American Medical Association (AMA) ,1991